RANKL Antikörper
Kurzübersicht für RANKL Antikörper (ABIN1822051)
Target
Alle RANKL (TNFSF11) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Human CD254.
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Recombinant human CD254.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: ELISA (0.15 - 0.3 μg/mL), WB (0.1 - 0.2 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Sterile 40-50 % glycerol.
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS. No preservative added
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Lyophilized powder may be stored at -20°C. Stable for 1 year at -20°C. Reconstitute by adding sterile 40-50% glycerol, aliquot and store at -20°C.
-
-
- RANKL (TNFSF11) (Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11))
-
Andere Bezeichnung
- TNFSF11 / RANKL / TRANCE
-
Hintergrund
-
Name/Gene ID: TNFSF11
Family: TNF
Synonyms: TNFSF11, CD254, CD254 antigen, HRANKL2, OPTB2, TRANCE, ODF, OPGL, SOdf, Osteoprotegerin ligand, RANKL -
Gen-ID
- 8600
-
UniProt
- O14788
-
Pathways
- NF-kappaB Signalweg
Target
-